Viewing Study NCT01338857

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:54 PM
Ignite Modification Date: 2026-01-26 @ 9:28 AM
Study NCT ID: NCT01338857
Status: TERMINATED
Last Update Posted: 2017-02-17
First Post: 2011-04-18
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Sorafenib in Children and Young Adults With Recurrent or Progressive Low-Grade Astrocytomas
Sponsor: NYU Langone Health
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None neurofibromatosis1 (NF1) View
None Recurrent or Progressive Optic Pathway Gliomas (OPG) View
None Recurrent or Progressive Low-grade Glioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None neurofibromatosis1 (NF1) View
None Recurrent or progressive optic pathway gliomas (OPG) View
None Recurrent or progressive low-grade glioma View
None sorafenib View
None low-grade astrocytoma View